{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:03:13Z","timestamp":1788397393299,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.transproceed.2017.11.008","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T00:35:29Z","timestamp":1517618129000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antibody Drug Treatment for Steroid-Resistant Rejection After Pediatric Living Donor Liver Transplantation: A Single-Center Experience"],"prefix":"10.1016","volume":"50","author":[{"given":"Y.","family":"Hirata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Urahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Katano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Otomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2017.11.008_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.clinre.2014.04.005","article-title":"Steroid-resistant acute rejection after cadaveric liver transplantation: experience from one single center","volume":"38","author":"Wu","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.transproceed.2017.11.008_bib2","first-page":"172","article-title":"Steroid-resistant acute rejections after liver transplant","volume":"8","author":"Aydogan","year":"2010","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2017.11.008_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1399-3046.2004.00152.x","article-title":"Studies of pediatric liver transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada","volume":"8","author":"Martin","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2017.11.008_bib4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.transproceed.2005.03.081","article-title":"Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss","volume":"37","author":"Bahra","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.11.008_bib5","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.transproceed.2006.07.032","article-title":"Changes in liver graft rejections over time","volume":"38","author":"Matinlauri","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.11.008_bib6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00007890-199511270-00008","article-title":"Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients","volume":"60","author":"Conti","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.11.008_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00007890-200001270-00019","article-title":"Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation","volume":"69","author":"Hirose","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.11.008_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40272-013-0034-4","article-title":"Management of acute rejection in paediatric liver transplantation","volume":"15","author":"Thangarajah","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.transproceed.2017.11.008_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/jlts.2002.34149","article-title":"Long-term survival and late graft loss in pediatric liver transplant recipients: a 15-year single-center experience","volume":"8","author":"Wallot","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2017.11.008_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00007890-199301000-00017","article-title":"OKT3 rescue for steroid-resistant rejection in adult liver transplantation","volume":"55","author":"Solomon","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.11.008_bib11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.transproceed.2012.01.008","article-title":"Veno-occlusive disease\/sinusoidal obstruction syndrome associated with potential antibody-mediated rejection after pediatric living donor liver transplantation: a case report","volume":"44","author":"Yamada","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.11.008_bib12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/00007890-200211150-00016","article-title":"Real-time monitoring of acute liver-allograft rejection using the Banff schema","volume":"74","author":"Demetris","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.11.008_bib13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document","volume":"25","author":"Anthony","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2017.11.008_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/01.TP.0000435701.54019.98","article-title":"A\u00a0comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients","volume":"97","author":"Benjamin","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.11.008_bib15","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1007\/s10620-010-1149-x","article-title":"Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation","volume":"55","author":"Schmitt","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.transproceed.2017.11.008_bib16","doi-asserted-by":"crossref","first-page":"E584","DOI":"10.1111\/j.1399-0012.2011.01494.x","article-title":"Anti-lymphocyte therapy successfully controls late \u201ccholestatic\u201d rejection in pediatric liver transplant recipients","volume":"25","author":"Kerkar","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2017.11.008_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/petr.12373","article-title":"Basiliximab treatment for steroid-resistant rejection in pediatric patients following liver transplantation for acute liver failure","volume":"18","author":"Shigeta","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2017.11.008_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF03189355","article-title":"OKT3 monitoring in the treatment of steroid-resistant acute rejection of hepatotransplant recipients","volume":"23","author":"Brusa","year":"1998","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.transproceed.2017.11.008_bib19","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/00007890-200206270-00020","article-title":"OKT3 (muromonab-CD3) associated hepatitis in a kidney transplant recipient","volume":"73","author":"Go","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.11.008_bib20","first-page":"1111","article-title":"OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection","volume":"27","author":"Platz","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.11.008_bib21","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1016\/j.transproceed.2005.07.052","article-title":"OKT3 treatment for steroid-resistant acute rejection in kidney transplantation","volume":"37","author":"Sevmis","year":"2005","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517308254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517308254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T11:32:53Z","timestamp":1635507173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134517308254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0041134517308254"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.11.008","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody Drug Treatment for Steroid-Resistant Rejection After Pediatric Living Donor Liver Transplantation: A Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}